D-histidina, mínimo 98 %, para bioquímica, 25 g, envase de plástico.

3-(3-aminopropyl)-1-phenyl-1H-pyrazol-5-amine dihydrochloride, 95.0%, 1g

METHYL 5-BROMO-2-MERCAPTOBENZOATE, 95.0%, 1g

D-Aspartic acid dibenzyl ester-p-toluenesulfonate, 98.0%, 25g

(1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 1g

ETHYL 3-(2,4,5-TRIFLUORO-3-METHYLPHENYL)-3-OXOPROPANOATE, 95.0%, 250mg

5-Methyl-isoxazole-4-carboxylic acid amide, 95.0%, 5g

6,8-difluoro-1,4-dihydroquinolin-4-one, 97%, 10g

ISAVUCONAZOLE, 98%, 1g

3,4,6-TRI-O-METHYL-D-GALACTAL, 95.0%, 1g

1-Acetyl-1H-indole-2-carboxylic acid, 95%, 250mg

4-Methyl-2-[1-(tert-butoxycarbonyl)piperid-4-yl]1,3-thiazole-5-carboxylic acid, 5g

Alcohol lignocerílico, 98%, para bioquímica, 250 mg, envase de vidrio